Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Journal of Biotechnology|October 18, 2016
Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical studyMahesh Kudrimoti, Amarintha Curtis, Samar Azawi, et al.
Head & Neck|February 26, 2017
Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancerAndrew Rosko, Andrew Birkeland, Andrew Shuman, et al.
Biotechnology Reports (Amsterdam, Netherlands)|June 27, 2017
Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patientsMahesh Kudrimoti, Amarinthia Curtis, Samar Azawi, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2008
Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective studyYue Cao, Aron Popovtzer, Diana Li, et al.
Cancers|January 11, 2024
Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001Filippo De Braud, Barbara Deschler-Baier, John C Morris, et al.
Head & Neck|June 15, 2013
Circulating CD4-positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancerNicholas A Dewyer, Gregory T Wolf, Emily Light, et al.
The Laryngoscope|June 28, 2016
Classification of TP53 mutations and HPV predict survival in advanced larynx cancerAdam Scheel, Emily Bellile, Jonathan B McHugh, et al.
JCO Clinical Cancer Informatics|January 13, 2023
Machine Learning Model of Emergency Department Use for Patients Undergoing Treatment for Head and Neck Cancer Using Comprehensive Multifactor Electronic Health RecordsCharles S Mayo, Michelle Mierzwa, Pratyusha Yalamanchi, et al.
Head & Neck|May 23, 2013
American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancerJohn A Ridge, Joshua Lawson, Sue S Yom, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 14, 2017
Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the LarynxDanielle L Gainor, Emily Marchiano, Emily Bellile, et al.
Pageof 7